Objectif
The aim of the MultiFun consortium is to develop and validate a novel and minimally-invasive nanotechnology system to improve cancer diagnosis and treatment. MultiFun nanotechnology is based on multifunctionalised magnetic nanoparticles to selectively target and eliminate breast and pancreatic cancer (stem) cells. The improved magnetic features of the MultiFun magnetic nanoparticles will lead to potential medical applications such as contrast agents and magnetic heating inductors. Moreover, magnetic nanoparticles can be functionalised with ligands to increase their affinity towards cancer cells in order to facilitate diagnosis of tumours by MRI. Targeting peptides and antibodies will be employed, including antibodies against cancer stem cells leading to early cancer detection by MRI means. The same nanoparticles will be used simultaneously as functional nanocarriers and heating inductors in order to provide a combined therapeutic modality. The synergistic effects of drugs, peptides, small RNAs and heat will be evaluated to determine the effectiveness of different therapeutic combinations. Interestingly, the use of ligands will favour the specific application of the therapeutic modalities to cancer (stem) cells, increasing the effectiveness and reducing side effects. Thus, MultiFun multimodal therapeutic approach is designed to efficiently remove cancer cells, including cancer stem cells, from the tumour site. The toxicity of functionalised magnetic nanoparticles will be assessed in vitro and in vivo to warrant a safe use and shed some light on the risks. The distribution and activity evaluation of functionalised nanoparticles will be performed in human breast and pancreatic cancer xenograft models. The use of novel magnetic nanoparticles for biomedical applications provides opportunities for new instrumentation: 1) detection and quantification of magnetic nanoparticles in blood, urine and tissues, and 2) magnetic heating induction for raising cell temperature.
Champ scientifique
- natural sciencesbiological sciencesbiochemistrybiomolecules
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- natural sciencesbiological sciencesgeneticsRNA
- engineering and technologynanotechnologynano-materials
- medical and health sciencesclinical medicineoncologypancreatic cancer
Programme(s)
Appel à propositions
FP7-NMP-2010-LARGE-4
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
28037 Madrid
Espagne
Voir sur la carte
Participants (16)
Participation terminée
28029 Madrid
Voir sur la carte
94010 Creteil
Voir sur la carte
28006 Madrid
Voir sur la carte
182 21 Praha 8
Voir sur la carte
28049 Madrid
Voir sur la carte
31077 TOULOUSE CEDEX 4
Voir sur la carte
WC2R 2LS London
Voir sur la carte
LL57 2UP BANGOR
Voir sur la carte
Participation terminée
50550 ZARAGOZA
Voir sur la carte
3001 Leuven
Voir sur la carte
28770 Madrid
Voir sur la carte
D02 CX56 DUBLIN 2
Voir sur la carte
T12 YN60 Cork
Voir sur la carte
07747 Jena
Voir sur la carte
M13 9PL Manchester
Voir sur la carte
E1 4NS London
Voir sur la carte